3B BLACKBIO DX LTD. Share Price

₹ 1,310.00

+₹14.30 (1.10%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: 3BBLACKBIO

3B BLACKBIO DX LTD. Share Price Today

As of 2 Nov 2026, 3B BLACKBIO DX LTD. share price is ₹1,310.00. The stock opened at ₹1,292.00, compared to its previous close of ₹1,295.70. During today's trading session, 3B BLACKBIO DX LTD. share price moved in the range of ₹1,292.00 to ₹1,382.60, with an average price of ₹1,337.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,085.00 and a high of ₹1,740.00. On the performance front, 3B BLACKBIO DX LTD. share price has increased by 8.04% over the last six months and is down 0.24% on a year-on-year basis.

₹1,292.00

1.10% up today

₹1,382.60

1D LOW

1D HIGH

3B BLACKBIO DX LTD. Stock Insights

Latest Earning

Op Profit TrendUp by 20.27% YoY

Latest Earning

Net Profit TrendUp by 25.67% YoY

Latest Earning

Revenue TrendUp by 50.14% YoY

Stock Performance

OutperformingBeat Nifty by 9.36 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.01%

Shareholding Pattern

DIIDII increased stake by 8.40%

Shareholding Pattern

FIIFII decreased stake by 1.87%

3B BLACKBIO DX LTD. Stock Insights

Latest Earning

Op Profit TrendUp by 20.27% YoY

Latest Earning

Net Profit TrendUp by 25.67% YoY

Latest Earning

Revenue TrendUp by 50.14% YoY

Stock Performance

OutperformingBeat Nifty by 9.36 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.01%

Shareholding Pattern

DIIDII increased stake by 8.40%

Shareholding Pattern

FIIFII decreased stake by 1.87%

3B BLACKBIO DX LTD. stock performance
Open	₹1,292.00
High	₹1,382.60
Low	₹1,292.00
Prev. close	₹1,295.70

3B BLACKBIO DX LTD. trading activity
Volume	9,902
Average traded price	₹1,329.59
Last traded time	03:29:32 02 Nov
Last traded quantity	3

₹1,036.60₹1,554.80

Circuit Low

Circuit High

₹1,085.00₹1,740.00

52-Week Low

52-Week High

Circuit

₹1,036.60

₹1,554.80

52-week

₹1,085.00

₹1,740.00

Mkt Cap Cr

1,112.53

P/E

19.77

P/B

3.43

ROA

14.88%

ROE

18.06%

ROCE

23.58%

Quick Ratio

5.91

EV/EBITDA

12.55

Mkt Cap Cr

1,112.53

P/E

19.77

P/B

3.43

ROA

14.88%

ROE

18.06%

ROCE

23.58%

Quick Ratio

5.91

EV/EBITDA

12.55

Based on fundamentals, this stock's

Performance

Very Poor

3B Blackbio has not beaten FD return of 7%

Valuation

Fairly Valued

3B Blackbio appears to be fairly valued compared to its peers

Earnings

Neutral

3B Blackbio earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Apollo Hospitals	1,20,779.11	55.61	12.74	9.79%	20.48%	17.27%	0.98	30.42
MANIPAL HEALTH ENTERPRI L	87,926.39	97.02	5.35	4.07%	10.59%	9.51%	1.17	34.66
Max Healthcare	83,704.68	60.65	7.39	7.37%	12.18%	13.24%	0.84	33.68
Aster DM Healthcare	59,570.09	164.28	14.16	4.47%	8.48%	10.1%	1.9	66.59
Fortis Healthcare	58,116.68	54.29	5.87	6.7%	10.53%	12.56%	0.8	28.03
Narayana Hrudayalaya	35,143.93	43.04	7.74	6.43%	17.17%	12.26%	2.07	19.68
Global Health	34,121.90	61.78	8.61	9.35%	14.05%	15.26%	2.54	32.32
Dr. Lal Path Labs	31,997.02	58.57	12.76	17.36%	20.13%	25.56%	3.38	34.28
KRISHNA INST OF MED SCI L	29,480.26	151.6	7.87	2.51%	10.74%	7.99%	0.68	39.1
Syngene International	16,251.72	87.33	3.34	2.79%	5.47%	7.06%	1.29	22.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

3B BLACKBIO DX LTD. Company Background

ISIN

INE994E01018

Sector Market Cap

₹ 1,112.53 Cr

3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.

3B BLACKBIO DX LTD. Financial Highlights

Revenue: 3B BLACKBIO DX LTD. reported revenue of ₹167.48 crore in FY26 vs ₹111.55 crore in FY25. It showed an increase of 50.14% on a yearly basis.
Operating Profit: 3B BLACKBIO DX LTD. reported an operating profit of ₹76.97 crore in FY26 vs ₹64.00 crore in FY25. It showed an increase of 20.27% on a year-on-year basis.
Net Profit: 3B BLACKBIO DX LTD. reported a net profit of ₹59.93 crore in FY26 vs ₹47.69 crore in FY25. It showed an increase of 25.67% on a yearly basis.

3B BLACKBIO DX LTD. Quarterly Result Highlights

3B BLACKBIO DX LTD. reported revenue of ₹39.63 crore in Jun 2026, compared with ₹45.58 crore in Mar 2026, representing a decrease of 13.05% on a quarter-on-quarter (QoQ) basis.
3B BLACKBIO DX LTD. reported an operating profit of ₹13.22 crore in Jun 2026, compared with ₹14.65 crore in Mar 2026, representing a decrease of 9.76% on a quarter-on-quarter (QoQ) basis.
3B BLACKBIO DX LTD. reported a profit of ₹8.98 crore in Jun 2026, compared with ₹9.80 crore in Mar 2026, reflecting a decrease of 8.37% on a QoQ basis.
The earnings per share (EPS) of 3B BLACKBIO DX LTD. stood at ₹55.66 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

40.95%

FII

2.46%

Other DII

2.33%

Retail and other

54.27%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	2.57%
Mar 2026	2.57%
Jun 2026	2.50%
Sep 2026	2.46%

3B BLACKBIO DX LTD. Investment Returns

1 day

-4.67%

1 week

-2.90%

1 month

-24.25%

1 year

-0.24%

3 years

-0.24%

5 years

-0.24%

3B BLACKBIO DX LTD. Share Price History

3B BLACKBIO DX LTD. share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
30 Oct 26	₹1,350.00 / ₹1,295.70	-4.67%
29 Oct 26	₹1,387.70 / ₹1,359.20	-0.28%
28 Oct 26	₹1,378.00 / ₹1,363.00	-1.35%
27 Oct 26	₹1,402.80 / ₹1,381.60	-0.80%
26 Oct 26	₹1,408.80 / ₹1,392.70	+4.37%
23 Oct 26	₹1,390.00 / ₹1,334.40	-1.10%
22 Oct 26	₹1,318.90 / ₹1,349.30	+2.30%
21 Oct 26	₹1,348.00 / ₹1,318.90	-0.92%
19 Oct 26	₹1,400.00 / ₹1,331.20	-7.96%
16 Oct 26	₹1,460.00 / ₹1,446.40	-0.69%

3B BLACKBIO DX LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹96.47	₹74.12	₹61.84	₹80.65
Other Income	₹15.08	₹12.53	₹7.26	₹6.90
Total Revenue	₹111.55	₹86.66	₹69.10	₹87.55
Total Expenses	₹47.55	₹42.33	₹33.79	₹44.33
Profit Before Tax	₹64.00	₹44.33	₹35.31	₹43.22
Tax	₹16.31	₹12.23	₹9.37	₹11.02
Profit After Tax	₹47.69	₹32.10	₹25.94	₹32.20
EPS - Basic	₹55.66	₹37.46	₹30.27	₹43.40
EPS - Diluted	₹55.66	₹37.46	₹30.27	₹43.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹64.00	₹44.33	₹35.31	₹43.22
Income before WC changes	₹59.13	₹39.38	₹33.75	₹44.00
Change in Assets	-₹2.11	-₹9.85	-₹2.38	₹30.65
Change in Liabilities	₹1.12	₹8.27	-₹2.14	-₹26.77
Change in WC	-₹0.99	-₹1.59	-₹4.52	₹3.89
Cash flow from Operations	₹43.36	₹26.95	₹20.28	₹37.33
Cash flow from Investing	-₹33.85	-₹20.32	₹14.73	-₹28.44
Cash flow from Financing	-₹3.22	-₹3.63	-₹5.01	-₹15.07
Total Cash Flow	₹6.29	₹3.01	₹30.01	-₹6.19
Cash (Start of the year)	₹62.15	₹59.21	₹28.89	₹35.08
Cash (End of the year)	₹68.83	₹62.15	₹59.21	₹28.89

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹163.53	₹124.71	₹99.82	₹110.55
Current Assets	₹132.19	₹123.40	₹114.24	₹81.54
Total Assets	₹295.72	₹248.10	₹214.06	₹192.09
Current Liabilities	₹18.59	₹17.53	₹14.18	₹16.90
Net Current Asset	₹113.60	₹105.86	₹100.05	₹64.64
Non-Current Liabilities	₹6.13	₹5.10	₹3.96	₹3.11
Equity Capital	₹271.00	₹225.47	₹195.91	₹172.08
Total Equity & Liabilities	₹295.72	₹248.10	₹214.06	₹192.09

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹97.28	₹90.53	₹70.72	₹59.34
Other Income	₹14.16	₹15.03	₹12.32	₹7.26
Total Revenue	₹111.44	₹105.56	₹83.04	₹66.60
Total Expenses	₹45.08	₹41.63	₹36.60	₹30.76
Profit Before Tax	₹66.36	₹63.93	₹46.44	₹35.84
Tax	₹17.04	₹16.37	₹12.23	₹9.42
Profit After Tax	₹49.32	₹47.56	₹34.21	₹26.42
EPS - Basic	₹57.56	₹55.51	₹39.93	₹30.85
EPS - Diluted	₹57.56	₹55.51	₹39.93	₹30.85

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹66.36	₹63.93	₹46.44	₹35.84
Income before WC changes	₹64.37	₹58.82	₹41.29	₹34.22
Change in Assets	-₹11.84	-₹0.70	-₹6.38	-₹1.93
Change in Liabilities	₹6.45	₹1.19	₹4.39	-₹2.15
Change in WC	-₹5.39	₹0.49	-₹1.99	-₹4.08
Cash flow from Operations	₹42.82	₹44.47	₹28.47	₹21.16
Cash flow from Investing	-₹19.80	-₹33.64	-₹20.32	-₹7.80
Cash flow from Financing	-₹6.55	-₹3.07	-₹3.62	-₹2.89
Total Cash Flow	₹16.47	₹7.76	₹4.53	₹10.46
Cash (Start of the year)	₹62.63	₹54.88	₹50.35	₹39.89
Cash (End of the year)	₹79.10	₹62.63	₹54.88	₹50.35

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹198.02	₹173.07	₹134.23	₹109.21
Current Assets	₹152.36	₹124.05	₹115.59	₹104.46
Total Assets	₹350.37	₹297.12	₹249.82	₹213.67
Current Liabilities	₹24.66	₹18.21	₹17.02	₹13.74
Net Current Asset	₹127.70	₹105.84	₹98.57	₹90.72
Non-Current Liabilities	₹6.70	₹6.13	₹5.02	₹3.83
Equity Capital	₹319.02	₹272.79	₹227.78	₹196.09
Total Equity & Liabilities	₹350.37	₹297.12	₹249.82	₹213.67